GSRGT

International society of scientists, experts, and patient advocates committed to improving the care of rare GU tumors through science and education

STRUCTURE of the SOCIETY

The GSRGT is composed by the leadership council and by focused groups dedicated to key topics of interest for advancing knowledge on rare GU tumors

Leadership Council

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Read more

Pathology Group

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Read more

Methodology Group

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Read more

Clinical Research Group

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Read more

Becoming a member has its perks. Sign up to become a member today!

250+

Members

200+

Abstracts

80+

Partners

Be A Member

With your support we can work together to secure the best possible outcomes for people with cancer.

Join Now

Member Benefits

We represent all doctors involved in the general care of patients, from training to consultant practice.

Upcoming Events

All Events
Zoom Meeting

2nd Global Society of Rare Genitourinary Tumors Summit

Icon October 12, 2018
Icon 8:00am - 12:30pm EST
Zoom Meeting

2nd Global Society of Rare Genitourinary Tumors Summit

Icon October 12, 2018
Icon 8:00am - 12:30pm EST
Zoom Meeting

2nd Global Society of Rare Genitourinary Tumors Summit

Icon October 12, 2018
Icon 8:00am - 12:30pm EST

Education Resources For You

International society of scientists, experts, and patient advocates committed to improving the care of rare GU tumors through science and education

News Feed

05 Jan 2018

Nectin-4 Emerges as a Therapeutic Target in Urothelial Carcinoma and Beyond

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer.

Find out more

05 Jan 2018

Nectin-4 Emerges as a Therapeutic Target in Urothelial Carcinoma and Beyond

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer.

Find out more

05 Jan 2018

Nectin-4 Emerges as a Therapeutic Target in Urothelial Carcinoma and Beyond

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, i

Find out more